Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,921 to 1,940 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A familial chromosomal complex rearrangement confirms RUNX1T1 as a causative gene for intellectual disability and suggests that 1p22.1p21.3 duplication is likely benign. | Mol Cytogenet | 2019 | 31223340 | PubTator, text mining | PubMed |
| Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia. | Nat Commun | 2019 | 31222014 | PubTator, text mining | PubMed |
| The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism. | Exp Mol Med | 2019 | 31221981 | PubTator, text mining | PubMed |
| MiR-193a-3p inhibits pancreatic ductal adenocarcinoma cell proliferation by targeting CCND1. | Cancer Manag Res | 2019 | 31213904 | PubTator, text mining | PubMed |
| [Analysis of induction efficacy and prognostic factors in FLT3-ITD positive acute myeloid leukemia in the real world]. | Zhonghua Xue Ye Xue Za Zhi | 2019 | 31207705 | PubTator, text mining | PubMed |
| [Application and challenges of the new generation detection technologies in precision medicine for leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2019 | 31207696 | PubTator, text mining | PubMed |
| Selective inhibition of Aurora A and B kinases effectively induces cell cycle arrest in t(8;21) acute myeloid leukemia. | Biomed Pharmacother | 2019 | 31207577 | PubTator, text mining | PubMed |
| Down-Regulation of PU.1 Gene in Pediatric Acute Lymphoblastic Leukemia Patients from South of Iran. | Int J Hematol Oncol Stem Cell Res | 2019 | 31205624 | PubTator, text mining | PubMed |
| Intersection of Epigenetic and Metabolic Regulation of Histone Modifications in Acute Myeloid Leukemia. | Front Oncol | 2019 | 31192132 | PubTator, text mining | PubMed |
| Acute myeloid leukemia patient with FLT3-ITD and NPM1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosis. | Cancer Manag Res | 2019 | 31190985 | PubTator, text mining | PubMed |
| Minimal Residual Disease Monitoring with Next-Generation Sequencing Methodologies in Hematological Malignancies. | Int J Mol Sci | 2019 | 31185671 | PubTator, text mining | PubMed |
| High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia. | J Transl Med | 2019 | 31171000 | PubTator, text mining | PubMed |
| [Acute myeloid leukemia evolving from KIT D816-mutated systemic mastocytosis relapsing two months after completion of chemotherapy]. | Rinsho Ketsueki | 2019 | 31167998 | PubTator, text mining | PubMed |
| CEBPE expression is an independent prognostic factor for acute myeloid leukemia. | J Transl Med | 2019 | 31164135 | PubTator, text mining | PubMed |
| Novel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia. | Molecules | 2019 | 31163672 | PubTator, text mining | PubMed |
| Di-(2-ethylhexyl)-phthalate induces apoptosis via the PPARγ/PTEN/AKT pathway in differentiated human embryonic stem cells. | Food Chem Toxicol | 2019 | 31163220 | PubTator, text mining | PubMed |
| The LL-100 panel: 100 cell lines for blood cancer studies. | Sci Rep | 2019 | 31160637 | PubTator, text mining | PubMed |
| The role of m6A RNA methylation in human cancer. | Mol Cancer | 2019 | 31142332 | PubTator, text mining | PubMed |
| Off to a Bad Start: Cancer Initiation by Pluripotency Regulator PRDM14. | Trends Genet | 2019 | 31130394 | PubTator, text mining | PubMed |
| Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia. | J Hematol Oncol | 2019 | 31126316 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=97